Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H. Fujimoto M, et al. Among authors: noguchi r. Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S. Alcohol Clin Exp Res. 2000. PMID: 10803780
Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group.
Fujimoto M, Uemura M, Kojima H, Ishii Y, Ann T, Sakurai S, Okuda K, Noguchi R, Adachi S, Kitano H, Hoppo K, Higashino T, Takaya A, Fukui H. Fujimoto M, et al. Among authors: noguchi r. Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):33S-38S. doi: 10.1111/j.1530-0277.1999.tb04531.x. Alcohol Clin Exp Res. 1999. PMID: 10235276
The effect of inflammatory cytokines in alcoholic liver disease.
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H. Kawaratani H, et al. Among authors: noguchi r. Mediators Inflamm. 2013;2013:495156. doi: 10.1155/2013/495156. Epub 2013 Dec 9. Mediators Inflamm. 2013. PMID: 24385684 Free PMC article. Review.
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
Yoshiji H, Noguchi R, Kojima H, Ikenaka Y, Kitade M, Kaji K, Uemura M, Yamao J, Fujimoto M, Yamazaki M, Toyohara M, Mitoro A, Fukui H. Yoshiji H, et al. Among authors: noguchi r. World J Gastroenterol. 2006 Nov 14;12(42):6786-91. doi: 10.3748/wjg.v12.i42.6786. World J Gastroenterol. 2006. PMID: 17106926 Free PMC article. Clinical Trial.
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.
Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, Kaji K, Aihara Y, Nishimura N, Takeda K, Okura Y, Kawaratani H, Fukui H. Douhara A, et al. Among authors: noguchi r. Mol Med Rep. 2015 Mar;11(3):1693-700. doi: 10.3892/mmr.2014.2995. Epub 2014 Nov 24. Mol Med Rep. 2015. PMID: 25421042 Free PMC article.
A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.
Namisaki T, Yoshiji H, Kuriyama S, Kojima H, Yoshii J, Ikenaka Y, Noguchi R, Sakurai S, Yanase K, Kitade M, Yamazaki M, Asada K, Tsujimoto T, Akahane T, Uemura M, Fukui H. Namisaki T, et al. Among authors: noguchi r. Hepatol Res. 2006 Jul;35(3):199-203. doi: 10.1016/j.hepres.2006.03.010. Epub 2006 May 22. Hepatol Res. 2006. PMID: 16716658
349 results